BOSTON--(BUSINESS WIRE)--Netcapital Inc. (the “Company”) (NASDAQ: NCPL, NCPLW), a digital private capital markets ecosystem, today announced the entry into definitive agreements for the immediate ...
When sued to enforce these warrant agreements, these issuers assert that the plaintiffs operate as 'unregistered dealers' and ...
TORONTO, April 17, 2025 (GLOBE NEWSWIRE) -- Inventus Mining Corp. (TSXV: IVS) (“Inventus” or the “Company”) is pleased to announce that the Company will make an application to the TSX Venture Exchange ...
SALT LAKE CITY, Utah, Sept. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics innovator specializing in biomedical applications of ...
Helius Medical Technologies, Inc. announced agreements with warrant holders to exercise nearly 4.97 million shares of common stock at a reduced price of $0.751 per share, generating approximately $3.7 ...
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN ...
NEWTOWN, Pa., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic ...
The exercise period for warrants series TO 12 ("TO 12") in Alligator Bioscience AB ("Alligator Bioscience" or the "Company") ended on 19 May 2025. The preliminary outcome indicates that a total of ...
CORVALLIS, Ore.--(BUSINESS WIRE)--NuScale Power Corporation (NYSE: SMR), the industry-leading provider of proprietary and innovative advanced nuclear small modular reactor (SMR) technology, today ...
Packaging Gateway on MSN
NYSE to delist Ardagh Metal Packaging warrants over low price
The NYSE cites an “abnormally low selling price” levels for the securities, which trade under the symbol AMBP.WS.
Carlsbad, CA, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (PALI) (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback